Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Amlodipine

NCT07704684 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

376

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Experimental: Sacubitril/Allisartan and Amlodipine Group
DRUG: Active Comparator: Amlodipine Group

Sponsor

Shenzhen Salubris Pharmaceuticals Co., Ltd.